1
|
Chen YA, Shie MY, Ho CC, Ye SW, Chen IWP, Shih YY, Shen YF, Chen YW. A novel label-free electrochemical immunosensor for the detection of heat shock protein 70 of lung adenocarcinoma cell line following paclitaxel treatment using l-cysteine-functionalized Au@MnO 2/MoO 3 nanocomposites. RSC Adv 2023; 13:29847-29861. [PMID: 37842680 PMCID: PMC10568263 DOI: 10.1039/d3ra03620k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Accepted: 09/09/2023] [Indexed: 10/17/2023] Open
Abstract
The future trend in achieving precision medicine involves the development of non-invasive cancer biomarker sensors that offer high accuracy, low cost, and time-saving benefits for risk clarification, early detection, disease detection, and therapeutic monitoring. A facile approach for the synthesis of MoO3 nanosheets was developed by thermally oxidizing MoS2 nanosheets in air followed by thermal annealing. Subsequently, Au@MnO2 nanocomposites were prepared using a combined hydrothermal process and in situ chemical synthesis. In this study, we present a novel immunosensor design strategy involving the immobilization of antiHSP70 antibodies on Au@MnO2/MoO3 nanocomposites modified on a screen-printed electrode (SPE) using EDC/NHS chemistry. This study establishes HSP70 as a potential biomarker for monitoring therapeutic response during anticancer therapy. Impedance measurements of HSP70 on the Au@MnO2/MoO3/SPE immunosensor using EIS showed an increase in impedance with an increase in HSP70 concentration. The electrochemical immunosensor demonstrated a good linear response in the range of 0.001 to 1000 ng mL-1 with a detection limit of 0.17 pg mL-1 under optimal conditions. Moreover, the immunosensor was effective in detecting HSP70 at low concentrations in a lung adenocarcinoma cell line following Paclitaxel treatment, indicating its potential for early detection of the HSP70 biomarker in organ-on-a-chip and clinical applications.
Collapse
Affiliation(s)
- Yi-An Chen
- x-Dimension Center for Medical Research and Translation, China Medical University Hospital Taichung City 404332 Taiwan
| | - Ming-You Shie
- x-Dimension Center for Medical Research and Translation, China Medical University Hospital Taichung City 404332 Taiwan
- The Master Program for Biomedical Engineering, China Medical University Taichung City 406040 Taiwan
- Department of Biomedical Engineering, China Medical University Taichung City 40447 Taiwan
| | - Chia-Che Ho
- Department of Bioinformatics and Medical Engineering, Asia University Taichung City 41354 Taiwan
| | - Sheng-Wen Ye
- The Master Program for Biomedical Engineering, China Medical University Taichung City 406040 Taiwan
| | - I-Wen Peter Chen
- Department of Chemistry, National Cheng Kung University Tainan 70101 Taiwan
| | - Yu-Yin Shih
- x-Dimension Center for Medical Research and Translation, China Medical University Hospital Taichung City 404332 Taiwan
| | - Yu-Fang Shen
- Department of Bioinformatics and Medical Engineering, Asia University Taichung City 41354 Taiwan
| | - Yi-Wen Chen
- x-Dimension Center for Medical Research and Translation, China Medical University Hospital Taichung City 404332 Taiwan
- The Master Program for Biomedical Engineering, China Medical University Taichung City 406040 Taiwan
- Department of Bioinformatics and Medical Engineering, Asia University Taichung City 41354 Taiwan
- Graduate Institute of Biomedical Sciences, China Medical University Taichung City 40447 Taiwan
| |
Collapse
|
2
|
Ye SW, Shen KF, Xiao M, Zhang PL, Zhang SY, Deng T, Huang L, Zhou XX. [A case of Hb M-Iwate combined with diffuse large B-cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi 2023; 44:607. [PMID: 37749047 PMCID: PMC10509627 DOI: 10.3760/cma.j.issn.0253-2727.2023.07.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Received: 01/18/2023] [Indexed: 09/27/2023]
Affiliation(s)
- S W Ye
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, China
| | - K F Shen
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, China
| | - M Xiao
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, China
| | - P L Zhang
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, China
| | - S Y Zhang
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, China
| | - T Deng
- Department of Hematology, The Fifth People's Hospital of Chongqing, Chongqing 400062, China
| | - L Huang
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, China
| | - X X Zhou
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, China
| |
Collapse
|
3
|
Li Z, Xie BC, Lyu PJ, Wang HX, Li Y, Wang CH, Li X, Ye SW, Li G, Pang PF, Zhang YY, Yu P. [Clinical value of nomogram model in evaluating the prognosis of cholangiocarcinoma after interventional therapy]. Zhonghua Yi Xue Za Zhi 2023; 103:1217-1224. [PMID: 37087405 DOI: 10.3760/cma.j.cn112137-20221124-02483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
Abstract
Objective: To investigate the clinical value and efficacy of the nomogram model in evaluating the prognosis of cholangiocarcinoma after interventional therapy. Methods: The clinical data of 259 patients with cholangiocarcinoma who received interventional therapy at the First Affiliated Hospital of zhengzhou University from January 2014 to June 2021 were retrospectively analyzed, including 148 males and 111 females, aged from 26 to 91 (65±12) years. They were randomly divided into a training group (181 cases) and a validation group (78 cases) in a ratio of 7∶3. Cox regression analysis was performed in the training group, independent risk factors affecting the prognosis of patients were screened, and a nomogram for 6-month, 1-year, and 2-year survival was constructed. The performance of the nomogram was analyzed by calculating the area under the receiver operating characteristic curve (AUC) value, calibration curve, and decision curve, and the predictive efficacy of the model was evaluated in the validation group. Results: There was no significant difference in baseline data between the training group and the validation group, which was comparable. Regression analysis showed that T stage (T2: HR=0.147,95%CI: 0.077-0.281;T3: HR=0.207,95%CI: 0.122-0.351;T4: HR=0.864,95%CI: 0.537-1.393), tumor diameter (17-33 mm: HR=0.201,95%CI: 0.119-0.341;≥33 mm: HR=0.795,95%CI: 0.521-1.211) and differentiation degree(middle differentiation: HR=3.318,95%CI: 2.082-5.289;highly differentiation: HR=1.842,95%CI: 1.184-2.867) were risk factors affecting the prognosis of interventional therapy for cholangiocarcinoma. The AUC values of the survival curve prediction models were generally consistent between the training and validation groups, and the AUC values of the training group at 6 months, 1 year, and 2 years were 0.925 (95%CI: 0.888-0.963), 0.921 (95%CI: 0.877-0.964) and 0.974 (95%CI: 0.957-0.993), respectively. In the validation group, the 6-month, 1-year, and 2-year AUC values were 0.951 (95%CI: 0.911-0.991), 0.917 (95%CI: 0.857-0.977) and 0.848 (95%CI: 0.737-0.959), respectively, and the AUC values were all greater than 0.8, suggesting that the nomogram had better discrimination ability. The calibration curves of the prediction models of the two groups were basically consistent, and the shape of the calibration curves at 6 months and 1 year fitted the ideal curve, while the fitting degree of the calibration curves at 2 years was relatively poor. The decision curve showed the high clinical utility of this nomogram in predicting the 6-month, 1-year survival of patients with cholangiocarcinoma. Conclusions: T stage, tumor diameter, and differentiation are independent risk factors affecting the prognosis of patients with interventional cholangiocarcinoma, and the nomogram model proposed in this study has good distinguishing ability and exact clinical value for prognosis evaluation.
Collapse
Affiliation(s)
- Z Li
- Department of Interventional Radiology, the First Affiliated Hospital of Zhengzhou University;Engineering Technology Research Center for Minimally Invasive Interventional Tumors of Henan Province,Zhengzhou 450052, China
| | - B C Xie
- Department of Interventional Radiology, the First Affiliated Hospital of Zhengzhou University;Engineering Technology Research Center for Minimally Invasive Interventional Tumors of Henan Province,Zhengzhou 450052, China
| | - P J Lyu
- Department of Radiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - H X Wang
- Department of Radiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - Y Li
- Department of Cardiology, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450014, China
| | - C H Wang
- Department of Magnetic Resonance, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - X Li
- Department of Interventional Radiology, the First Affiliated Hospital of Zhengzhou University;Engineering Technology Research Center for Minimally Invasive Interventional Tumors of Henan Province,Zhengzhou 450052, China
| | - S W Ye
- Department of Interventional Radiology, the First Affiliated Hospital of Zhengzhou University;Engineering Technology Research Center for Minimally Invasive Interventional Tumors of Henan Province,Zhengzhou 450052, China
| | - G Li
- Department of Interventional Radiology, Zhengzhou First People's Hospital, Zhengzhou 450004, China
| | - P F Pang
- Department of Interventional Radiology, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, China
| | - Y Y Zhang
- Department of Interventional Radiology, the First Affiliated Hospital of Zhengzhou University;Engineering Technology Research Center for Minimally Invasive Interventional Tumors of Henan Province,Zhengzhou 450052, China
| | - P Yu
- Department of Interventional Radiology, the First Affiliated Hospital of Zhengzhou University;Engineering Technology Research Center for Minimally Invasive Interventional Tumors of Henan Province,Zhengzhou 450052, China
| |
Collapse
|
4
|
Wu AW, Gu J, Wang J, Ye SW, An Q, Yao YF, Zhan TC. Results after change of treatment policy for rectal cancer – report from a single hospital in China. Eur J Surg Oncol 2007; 33:718-23. [PMID: 17240113 DOI: 10.1016/j.ejso.2006.12.011] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2006] [Accepted: 12/05/2006] [Indexed: 10/23/2022] Open
Abstract
BACKGROUND Great changes have occurred in the management of rectal cancer. This study presents the outcome of total mesorectal excision (TME) for rectal cancer in a single Chinese institution and evaluates TME's role in the comprehensive management of rectal cancer. METHODS We reviewed the data of rectal cancer patients surgically treated by three colorectal surgeons from January 2000 to August 2004. Patients who received surgical resection for rectal cancer from January 1996 to December 1999, before the introduction of TME, were chosen as controls. Data regarding characteristics of patients and tumors, surgical procedures, postoperative complications, and results of follow-up were collected for analysis. RESULTS Three hundred and seventy-seven patients with rectal cancer were enrolled in our study, with 175 patients in the TME group and 202 as controls. Mortality and morbidity rates were 1% and 14% in TME patients and 1% and 31% in controls, respectively. The TME group had a shorter operation time and hospital stay, and less bleeding, wound and urinary complications. The local recurrence (LR) rate was 6% and 12% in the TME and the control groups, respectively (P<0.05). With a median follow-up of 35 months, the actuarial 5-year survival rate was 66%. Consistent with the univariate analysis result, multivariate analysis demonstrated that TNM stage, tumor grade, age, and surgeons were independent prognostic factors. TME was not an independent prognostic factor for patients' survival. CONCLUSIONS TME is a safe and efficient option in reducing LR. However, it is not an independent predictor for patients' survival. In addition to the standardized usage of TME, further knowledge on the molecular mechanism of cancer is needed.
Collapse
Affiliation(s)
- A W Wu
- Department of Colorectal Surgery, School of Oncology, Peking University, Beijing Institute for Cancer Research, Beijing Cancer Hospital, Fucheng Road, No. 52, Haidian District, Beijing 100036, China
| | | | | | | | | | | | | |
Collapse
|
5
|
Bai JZ, Ban Y, Bian JG, Chen AD, Chen HF, Chen HS, Chen JC, Chen XD, Chen YB, Cheng BS, Chi SP, Chu YP, Choi JB, Cui XZ, Dai YS, Dong LY, Du ZZ, Dunwoodie W, Fu HY, Fu LP, Gao CS, Gu SD, Guo YN, Guo ZJ, Han SW, Han Y, Harris FA, He J, He JT, He KL, He M, He X, Hong T, Heng YK, Hu GY, Hu HM, Hu QH, Hu T, Huang GS, Huang XP, Huang YZ, Izen JM, Ji XB, Jiang CH, Jin Y, Jones BD, Kang JS, Ke ZJ, Kim HJ, Kim SK, Kim TY, Kong D, Lai YF, Li D, Li HB, Li HH, Li J, Li JC, Li PQ, Li QJ, Li RY, Li W, Li WG, Li XN, Li XQ, Liu B, Liu F, Liu F, Liu HM, Liu J, Liu JP, Liu TR, Liu RG, Liu Y, Liu ZX, Lou XC, Lu GR, Lu F, Lu JG, Lu ZJ, Luo XL, Ma EC, Ma JM, Malchow R, Mao HS, Mao ZP, Meng XC, Mo XH, Nie J, Nie ZD, Olsen SL, Paluselli D, Park H, Qi ND, Qi XR, Qian CD, Qiu JF, Que YK, Rong G, Shao YY, Shen BW, Shen DL, Shen H, Shen XY, Sheng HY, Shi F, Shi HZ, Song XF, Suh JY, Sun HS, Sun LF, Sun YZ, Tang SQ, Toki W, Tong GL, Varner GS, Wang J, Wang JZ, Wang L, Wang LS, Wang P, Wang PL, Wang SM, Wang YY, Wang ZY, Wei CL, Wu N, Xi DM, Xia XM, Xie XX, Xu GF, Xu Y, Xue ST, Yan WB, Yan WG, Yang CM, Yang CY, Yang GA, Yang HX, Yang W, Yang XF, Ye MH, Ye SW, Ye YX, Yu CS, Yu CX, Yu GW, Yuan Y, Zhang BY, Zhang C, Zhang CC, Zhang DH, Zhang HL, Zhang HY, Zhang J, Zhang JW, Zhang L, Zhang LS, Zhang P, Zhang QJ, Zhang SQ, Zhang XY, Zhang YY, Zhang ZP, Zhao DX, Zhao HW, Zhao J, Zhao JW, Zhao M, Zhao PP, Zhao WR, Zhao YB, Zhao ZG, Zheng JP, Zheng LS, Zheng ZP, Zhou BQ, Zhou GM, Zhou L, Zhu KJ, Zhu QM, Zhu YC, Zhu YS, Zhu ZA, Zhuang BA, Zou BS. Measurements of the cross section for e(+)e(-) --> hadrons at center-of-mass energies from 2 to 5 GeV. Phys Rev Lett 2002; 88:101802. [PMID: 11909342 DOI: 10.1103/physrevlett.88.101802] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/03/2001] [Indexed: 05/23/2023]
Abstract
We report values of R = sigma(e(+)e(-)-->hadrons)/sigma(e(+)e(-)-->mu(+)mu(-)) for 85 center-of-mass energies between 2 and 5 GeV measured with the upgraded Beijing Spectrometer at the Beijing Electron-Positron Collider.
Collapse
Affiliation(s)
- J Z Bai
- Institute of High Energy Physics, Beijing 100039, People's Republic of China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|